Skip to main content

Williams Frank J's Form 4 filing

Evolent Health, Inc. (EVH) · filed Jul 13, 2021

Accession no.
0001628908-21-000100
Filed
Jul 13, 2021
Trade date
Jul 9, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $164.9K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Williams Frank JCIK 0001204938Director, Officer (Executive Chairman)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 9, 2021Class A Common StockSSaleDisposed−3,584$23.00−$82,432671,494Direct
Jul 9, 2021Class A Common StockMOption exerciseAcquired+3,584$3.84+$13,762.56675,078Direct
Jul 9, 2021Class A Common StockSSaleDisposed−3,584$23.00−$82,432671,494Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 9, 2021Class A Common StockMOption exerciseDisposed−3,584$0.00$0712,976Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)